Boston Scientific Corporation (NYSE: BSX) is terminating its $230 million plan to buy a majority stake in M.I. Tech, a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures.
Regulatory Hurdles Force Boston Scientific to Opt for Minority Stake in M.I. Tech
